June 24, 2017 11:02 AM ET

Pharmaceuticals

Company Overview of AbGenomics International, Inc.

Company Overview

AbGenomics International, Inc., a biopharmaceutical company, engages in the development of treatments and prevention against inflammatory/autoimmune disease and cancer. It provides Neihulizumab/AbGn-168H, a humanized therapeutic antibody with a mechanism of action; AbGn-107, an antibody equipped with AbG's linker-payload that targets novel tumor-associated antigens on the surface of certain stomach, pancreatic, and colorectal cancers; AbGn-110, a solution for the treatment of breast and gastric tumors; and AbGn-108, a biobetter/biosuperior ADC for lung and ovarian cancers. AbGenomics International was founded in 2000 and is based in Los Altos, California with a research and development cente...

4966 El Camino Real

Suite 200

Los Altos, CA 94022

United States

Founded in 2000

Phone:

650-537-4908

Fax:

650-988-9913

Key Executives for AbGenomics International, Inc.

Founder, Chairman of the Board and Chief Executive Officer
Chief Operating Officer
Chief Medical Officer and President of AbG BV
Vice President of Operations for AbG US
Vice President of Project and Alliance Management
Compensation as of Fiscal Year 2016.

AbGenomics International, Inc. Key Developments

AbGenomics International, Inc. Presents at Annual Sofinnova Japan Biopharma Partnering Conference, Oct-25-2016 09:35 AM

AbGenomics International, Inc. Presents at Annual Sofinnova Japan Biopharma Partnering Conference, Oct-25-2016 09:35 AM. Venue: Conrad Hotel, 1-9-1, Higashi-Shinbashi, Minato-Ku, Tokyo, 105 7337, Japan.

AbGenomics International, Inc. Presents at 14th Annual BIO Investor Forum, Oct-21-2015 10:00 AM

AbGenomics International, Inc. Presents at 14th Annual BIO Investor Forum, Oct-21-2015 10:00 AM. Venue: Parc 55 Hotel, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AbGenomics International, Inc., please visit www.abgenomics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.